Transparency Market Research Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Single User License:
USD 4595 Multi User License:
USD 7595 Corporate User License:
USD 10595 87 Page Report
Published Date 28-February-2014 Buy Now
Request Sample
Press Release
Global Pharmacovigilance Market Expected to Reach USD 5.0 Billion Globally in 2019: Transparency Market Research
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Pharmacovigilance Market
REPORT DESCRIPTION Transparency Market Research Report published "Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its database. A rising tide of regulatory expectations, tougher inspection regime and instant need of patient reporting has provided the much needed impetus for the growth of the pharmacovigilance market. An upsurge in number of acute and chronic diseases has consequently led to a rise in number of drug consumption, which has also elicited a growth in the number of adverse drug events and drug toxicity cases. Browse the report with Full TOC at http://www.transparencymarketresearch.com/pharmacovigilance-market.html Moreover, several high-profile safety issues, regulatory warnings, large volume of events to be reviewed along with negative media coverage have compelled the pharmaceutical players to take support of various outsourcing services. There are two major outsourcing services opted by these pharmaceutical players i.e. traditional CROs and BPOs. These outsourcing services not only provide cost savings but also helps in bringing process efficiency. Pharmaceutical companies are now forming long term partnership with the CROs and BPOs to share the costs involved in PV process right from drug discovery to post marketing approvals. In addition, PV requires skilled resources with excellent language skills and strong knowledge pertaining to case reporting. Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=1729 The research report on pharmacovigilance provides detailed analysis of the global market and helps in understanding the driving forces responsible for the growth of this market. The report discusses the market of pharmacovigilance market on the bases of clinical trials phases i.e. Phase I to III and post marketing surveillance (PMS). We have also mapped the trend for preference of the pharmaceutical players for in-house and outsourcing in our chapter by type of service. The global pharmacovigilance market has been segmented based on all the above mentioned parameters and market size estimates and forecasts for the period of 2011 to 2019 have been provided for each of the segments, in term of USD million, considering 2012 as the base year for calculations and 2011 representing as the historical year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has also been provided along with market size estimations. The report exclusively studies the aforementioned segments with respect to geography. Under geographic section we have covered four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (ROW).
Transparency Market Research
2
Prenatal and Newborn Genetic Testing Market
Bowse more healthcare IT related report at http://www.transparencymarketresearch.com/healthcareit-market-reports-19.html The market overview section gives a detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global pharmacovigilance market. The section also covers opportunities and market attractiveness analysis of the geographical regions. The report concludes with the competitive landscape and company profiles of major market players. These market players have been profiled on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report include PRA International Inc., Covance Inc., Synowledge LLC, OptumInsight Inc., iMedGlobal, TCS, iGATE Corporation, Cognizant Technology Solutions, Quintiles and others. TABLE OF CONTENT
Chapter 1 Introduction 1.1 Report Description 1.2 Research Methodology 1.3 Market Segmentation
Chapter 2 Executive Summary
Chapter 3 Global Pharmacovigilance Market Dynamics 3.1 Introduction 3.1.1 Drivers 3.1.1.1 Rise in number of drug consumption 3.1.1.2 Rise in drug toxicity cases producing significant morbidity and mortality
Transparency Market Research
3
Prenatal and Newborn Genetic Testing Market
3.1.1.3 Embracing new technologies to mitigate risk 3.1.1.4 Rise in adoption of pharmacovigilance outsourcing services 3.1.1.5 Globalization of drug development with shift from manufacturing activities from high cost to low cost regions 3.1.2 Restraints 3.1.2.1 Stringent and varied regulatory approval processes
Browse the report with Full TOC at http://www.transparencymarketresearch.com/pharmacovigilancemarket.html
3.1.3 Challenges 3.1.3.1 Lack of availability of skilled labor 3.2 Porter’s Five Force Analysis: Global Pharmacovigilance Market 3.2.1 Bargaining Power of Suppliers 3.2.2 Bargaining Power of Buyers 3.2.3 Threat of New Entrants 3.2.4 Threat of Substitutes 3.2.5 Competitive Rivalry 3.3 Market Attractiveness Analysis of the Global Pharmacovigilance Market, by Geography 3.3.1 Market Attractiveness Analysis: Global Pharmacovigilance Market, 2012, by Geography
Chapter 4 Global Pharmacovigilance Market, by Clinical Trial Phases
Transparency Market Research
4
Prenatal and Newborn Genetic Testing Market
4.1 Overview 4.1.1 Preclinical Studies 4.1.1.1 Global Preclinical Studies Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 4.1.2 Phase I trial 4.1.2.1 Global Clinical Trial Phase I Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 4.1.3 Phase II trial 4.1.3.1 Global Clinical Trial Phase II Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 4.1.4 Phase III trial 4.1.4.1 Global Clinical Trial Phase III Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 4.1.5 Phase IV trial (Post marketing surveillance) 4.1.5.1 Global Clinical Trial Phase IV Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million)
Chapter 5 Global Pharmacovigilance Market, By Type of Methods 5.1 Overview 5.1.1 Spontaneous Reporting 5.1.1.1 Global Spontaneous Drug Safety Reporting Market Revenue, 2011 – 2019 (USD Million) 5.1.2 Targeted Reporting 5.1.2.1 Global Targeted Drug Safety Reporting Market Revenue, 2011 – 2019 (USD Million) 5.1.3 Cohort Event Monitoring 5.1.3.1 Global Cohort Event Monitoring Market Revenue, 2011 – 2019 (USD Million)
Transparency Market Research
5
Prenatal and Newborn Genetic Testing Market
5.1.4 EHR Monitoring 5.1.4.1 Global Electronic Health Records (EHR) Monitoring Market Revenue, 2011 – 2019 (USD Million) 5.1.5 Intensified ADR Reporting 5.1.5.1 Global Intensified ADR Reporting Market Revenue, 2011 – 2019 (USD Million)
Browse the report with Full TOC at http://www.transparencymarketresearch.com/pharmacovigilance-market.html
Chapter 6 Global Pharmacovigilance Market, by Type of Service Providers 6.1 Overview 6.1.1 In-House 6.1.1.1 Global In-House Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 6.1.2 Contract Outsourcing 6.1.2.1 Global Contract Outsourcing Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million)
Chapter 7 Global Pharmacovigilance Market, by Geography 7.1 Overview 7.1.1 Comparative Analysis: Global Pharmacovigilance Market, by Geography, 2012 & 2019 (Value %) 7.2 North America 7.2.1 North America Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million)
Transparency Market Research
6
Prenatal and Newborn Genetic Testing Market
7.3 Europe 7.3.1 Europe Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 7.4 Asia Pacific 7.4.1 Asia-Pacific Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million) 7.5 Rest of the World 7.5.1 Rest of the World Pharmacovigilance Market Revenue, 2011 – 2019 (USD Million)
Chapter 8 Global Pharmacovigilance Market Share Analysis 8.1 Market Share Analysis by Key Players of Global Pharmacovigilance Market 8.1.1 Global CRO Market Share Analysis, by Key Players, 2012 (%)
Chapter 9 Recommendations 9.1 Success Strategies 9.1.1 Developing Strategic Alliances and Partnerships With CROs and Life Science BPOs Companies 9.1.2 Hub and Spoke model to optimize drug safety 9.1.3 Enhancing operational activities for better outcomes 9.1.4 Expand Market into Emerging Countries
Chapter 10 Company Profiles 10.1 Accenture, Plc 10.1.1 Company Overview
Transparency Market Research
7
Prenatal and Newborn Genetic Testing Market
10.1.2 Financial Overview 10.1.3 Product Portfolio 10.1.4 Business Strategies 10.1.4.1 Mergers and acquisitions 10.1.5 Recent Developments 10.2 Bristol-Myers Squibb 10.2.1 Company Profile 10.2.2 Financial overview 10.2.3 Product Portfolio 10.2.4 Business Strategies 10.2.4.1 Strategic collaboration 10.2.4.2 Research and Development Initiatives 10.2.4.3 Recent Developments 10.3 Clinquest Group B.V. 10.3.1 Company Overview 10.3.2 Product Portfolio 10.3.3 Business Strategies 10.3.3.1 Strategic partnership 10.3.4 Recent Developments 10.4 Cognizant Technology Solutions 10.4.1 Company Overview 10.4.2 Financial Overview
Transparency Market Research
8
Prenatal and Newborn Genetic Testing Market
10.4.3 Product Portfolio
Browse the report with Full TOC at http://www.transparencymarketresearch.com/pharmacovigilancemarket.html
10.4.4 Business Strategies 10.4.4.1 Expansion of geographical footprint 10.4.4.2 Expansion of product portfolio 10.4.4.3 Highly-skilled manpower 10.4.4.4 Strategic acquisitions 10.4.5 Recent Developments 10.5 Covance, Inc. 10.5.1 Company Overview 10.5.2 Financial Overview 10.5.3 Product Portfolio 10.5.4 Business Strategies 10.5.4.1 New product development and innovation 10.5.4.2 Agreements and collaborations 10.5.4.3 Strategic acquisitions 10.5.4.4 Geographical expansion of business 10.5.5 Recent Developments 10.6 GlaxoSmithKline (GSK)
Transparency Market Research
9
Prenatal and Newborn Genetic Testing Market
10.6.1 Company Overview 10.6.2 Financial overview 10.6.3 Product Portfolio 10.6.4 Business strategies 10.6.4.1 Research and development initiatives 10.6.4.2 Direct to Consumer Advertising 10.6.4.3 Mergers and acquisitions 10.6.5 Recent developments 10.7 ICON, Plc 10.7.1 Company Overview 10.7.2 Financial Overview 10.7.3 Product Portfolio 10.7.4 Business Strategies 10.7.4.1 Business expansion in APAC region 10.7.4.2 Expansion of services offered 10.7.5 Recent Developments 10.8 iGATE Corporation 10.8.1 Company Overview 10.8.2 Financial Overview 10.8.3 Product Portfolio 10.8.4 Business Strategies 10.8.4.1 Strategic Acquisition
Transparency Market Research
10
Prenatal and Newborn Genetic Testing Market
10.8.5 Recent Developments 10.9 iMEDGlobal Corporation 10.9.1 Company Overview 10.9.2 Product Portfolio 10.9.3 Business Strategies 10.9.3.1 Geographical Expansion 10.9.4 Recent Developments 10.10 Infosys 10.10.1 Company Overview 10.10.2 Financial Overview 10.10.3 Product Portfolio 10.10.4 Business Strategies 10.10.4.1 Extensive product portfolio 10.10.4.2 Geographical expansion of business 10.10.5 Recent Developments 10.11 inVentiv Health Inc. 10.11.1 Company Overview 10.11.2 Product Portfolio 10.11.3 Business Strategies 10.11.3.1 Strategic Partnership 10.11.3.2 Strategic Acquisition 10.11.4 Recent Developments
Transparency Market Research
11
Prenatal and Newborn Genetic Testing Market
10.12 Johnson and Johnson 10.12.1 Company Profile 10.12.2 Financial Overview 10.12.3 Product Portfolio 10.12.4 Business Strategies
Browse the report with Full TOC at http://www.transparencymarketresearch.com/pharmacovigilancemarket.html
10.12.4.1 Extensive Research and Development Investments 10.12.4.2 Strategic Collaborative Arrangements 10.12.4.3 Recent Developments 10.13 Novartis International AG 10.13.1 Company Overview 10.13.2 Financial Overview 10.13.3 Product Portfolio 10.13.4 Business Strategy 10.13.4.1 Mergers and Acquisitions 10.13.5 Recent Developments 10.14 OptumInsight, Inc. 10.14.1 Company Overview 10.14.2 Product Portfolio
Transparency Market Research
12
Prenatal and Newborn Genetic Testing Market
10.14.3 Business Strategies 10.14.3.1 Strategic product launch 10.14.3.2 Strategic collaboration 10.14.4 Recent Developments 10.15 Parexel International Corporation 10.15.1 Company Overview 10.15.2 Financial Overview 10.15.3 Product Portfolio 10.15.3.1 Strong presence in Asia and emerging markets 10.15.3.2 Strategic alliances 10.15.3.3 Mergers & Acquisitions 10.15.4 Recent Developments 10.16 Pfizer, Inc. 10.16.1 Company Overview 10.16.2 Financial Overview 10.16.3 Product Portfolio 10.16.4 Business Strategies 10.16.4.1 Acquisitions 10.16.5 Recent Developments 10.17 Pharmaceutical Product Development, Inc. (PPD, Inc.) 10.17.1 Company Overview 10.17.2 Product Portfolio
Transparency Market Research
13
Prenatal and Newborn Genetic Testing Market
10.17.3 Business Strategies 10.17.3.1 Expanding geographic presence 10.17.3.2 Incorporation of innovative technologies 10.17.3.3 Strategic acquisitions 10.17.3.4 New product launch and innovation 10.17.4 Recent Developments 10.18 PRA International, Inc. 10.18.1 Company Overview 10.18.2 Product Portfolio 10.18.3 Business Strategies 10.18.3.1 Mergers and acquisitions 10.18.4 Recent Developments 10.19 Quantum Solutions India 10.19.1 Company Overview 10.19.2 Product Portfolio 10.19.3 Business Strategies 10.19.3.1 Strategic Collaborations 10.20 Quintiles Transnational Corporation 10.20.1 Company Overview 10.20.2 Financial Overview 10.20.3 Product Portfolio 10.20.4 Business Strategies
Transparency Market Research
14
Prenatal and Newborn Genetic Testing Market
10.20.4.1 Expansion of services 10.20.4.2 Acquisitions and partnerships 10.20.4.3 Innovation in services offered 10.20.5 Recent Developments
Browse the report with Full TOC at http://www.transparencymarketresearch.com/pharmacovigilancemarket.html
10.21 F. Hoffmann-La Roche Ltd. 10.21.1 Company Overview 10.21.2 Financial Overview 10.21.3 Product Portfolio 10.21.4 Business Strategies 10.21.4.1 Licensing Agreement 10.21.4.2 Product portfolio expansion 10.22 Sanofi Aventis 10.22.1 Company Overview 10.22.2 Financial Overview 10.22.3 Product Portfolio 10.22.4 Business Strategy 10.22.4.1 Renewal of cooperation protocol 10.22.4.2 Recent developments
Transparency Market Research
15
Prenatal and Newborn Genetic Testing Market
10.23 Synowledge LLC 10.23.1 Company Overview 10.23.2 Product Portfolio 10.23.3 Business Strategies 10.23.3.1 Geographical Expansion 10.23.3.2 Strategic Partnership 10.23.4 Recent Developments 10.24 United BioSource Corporation 10.24.1 Company Overview 10.24.2 Product Profiling 10.24.3 Business Strategies 10.24.3.1 Strategic acquisitions 10.25 Wipro Limited 10.25.1 Company Overview 10.25.2 Financial Overview 10.25.3 Product Portfolio 10.25.4 Business Strategies 10.25.4.1 Geographical expansion
Transparency Market Research
16
Prenatal and Newborn Genetic Testing Market
About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Blog: https://tmrresearch.wordpress.com/
Transparency Market Research
17